Drug Eluting Stents
Exploring the likely effect of the introduction of drug eluting stents on requirements for coronary artery revascularisation procedures in Western Australia: a use of the CHD/CARP Markov Simulation Model
... when stents were introduced and there was also a shift towards doing more PCIs and less CABGs, especially in older ...of drug-eluting-stents ...
5
Long-term effectiveness and safety of sirolimus drug-eluting stents
... the drug-eluting stent over the past decade has revolutionized the field of interventional ...first drug-eluting stent to receive US Food and Drug Administration approval was the ...
8
The benefits of drug-eluting stents in the treatment of coronary artery disease
... coronary stents has been a landmark development in the treatment of coronary artery disease with percutaneous coronary ...coronary stents, initially bare-metal stents (BMS), the problems of ...
17
Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
... comparing drug-eluting stents (DES) and bare metal stents (BMS) for percutaneous coronary intervention (PCI) have consistently shown lower mortality and myocardial infarction associated with ...
9
A three-dimensional mathematical model for drug delivery from drug-eluting stents
... The stents are coated with a drug that is slowly eluted to prevent the growth of scar tissue in the artery ...flow. Drug-eluting stents are safe and effective in most circumstances, ...
13
Some design considerations for polymer-free drug-eluting stents : a mathematical approach
... Drug-eluting stents (DES) have significantly improved the treat- ment of coronary heart disease (CHD) and are the current gold standard in percutaneous coronary interventions ...small ...
13
Drug eluting stents versus bare metal stents in coronary artery disease patients: outcomes and complications
... of drug- eluting stents (DES) versus bare metal stents (BMS) after implantation in coronary artery disease (CAD) patients up to 6months follow-up ...
6
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers
... of drug-eluting stents in preventing restenosis has shifted the focus of new stent development toward enhancing long term safety and efficacy of these devices, while simultaneously eliminating the ...
9
COMPARISON OF BARE METAL VERSUS DRUG ELUTING STENTS
... metal stents and drug eluting stents in 1 month follow ...or drug eluting stents (150 patients of each type of ...metal stents while half was deployed drug ...
7
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
... coronary stents, particularly in lowering the rates of restenosis occurrence after percutaneous coron- ary stenting with drug-eluting stents (DESs) rather than after percutaneous coronary ...
12
Simulating drug-eluting stents : progress made and the way forward
... coated stents and polymer-free surface- modified ...these stents is not diffusion and so models which assume purely diffusion may not cap- ture the release ...in-vitro drug release profile of ...
9
Comparison of Bypass Surgery with Drug Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis
... underwent drug-eluting stent (DES) implantation and 116 pa- tients who underwent CABG in a single hospital in China between January 2004 and December ...
10
Novel drug-eluting stents in the treatment of de novo coronary lesions
... biodegradable stents represent a new concept of coronary ...Biodegradable stents completely degrade after implantation and, causing the disappearance of any foreign material exposed to blood if ...
16
Meta-analysis of Trials Comparing Drug-eluting Stents with Bare Metal Stents: Safety and Efficacy
... The application of DESs has put a substantial dent in restenosis which was a well-known and potentially hazardous complication of BMS [1-7]. On the basis of this finding, their implantation has become increasingly common ...
19
Formation of microcapsules by ultrasound stimulation for use in remote-controlled drug-eluting stents
... Rhodamine 6G concentration in Figure 6 showed that 290 samples after high-duty cycle ultrasonic stimulation carried out 6 times, 15 minutes each time, released 291 more of the dye than u[r] ...
24
Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
... A tornado diagram of the one-way deterministic analyses shows the effect on the estimated ICER if one model assumption is altered while other assumptions remain at base case values ( fi gure 2). Only parameters that lead ...
8
Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting
... Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team [r] ...
7
Factors that affect mass transport from drug eluting stents into the artery wall
... arterial drug uptake. Stents are often deployed at sites of throm- bus and after implantation a clot will inevitably develop once the struts become cov- ered with plasma ...alter drug distribution ...
16
Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
... sirolimus-eluting stents (Firebird2; MicroPort Medi- cal, ...sirolimus-eluting stents (FIREHAWK; MicroPort Medical, China, Excel; JW Medical, China, BuMA; Sino Medical, China, NOYA; Medfavour ...
12
High performance simulation of drug release model and mass transport model by using hybrid platform
... controlled drug delivery in drug eluting stents exerts an important influence in decreasing restenosis in intravascular ...These stents are coated with drug to avoid the re- ...
51